Ability of ELISAs to detect antibodies against porcine respiratory and reproductive syndrome virus in serum of pigs after inactivated vaccination and subsequent challenge

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

ISSN: 1746-6148

Extent: Online-Ressource

Language: Englisch

Notes: online resource.

Bibliographic citation: Ability of ELISAs to detect antibodies against porcine respiratory and reproductive syndrome virus in serum of pigs after inactivated vaccination and subsequent challenge ; volume:12 ; number:1 ; day:21 ; month:11 ; year:2016 ; pages:1-6 ; date:12.2016
BMC veterinary research ; 12, Heft 1 (21.11.2016), 1-6, 12.2016

Creator: Sattler, Tatjana

Contributor: Pikalo, Jutta
Wodak, Eveline
Schmoll, Friedrich
SpringerLink (Online service)

DOI: 10.1186/s12917-016-0888-0

URN: urn:nbn:de:1111-201612118115

Rights: Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 14.08.2025, 10:49 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Sattler, Tatjana
Pikalo, Jutta
Wodak, Eveline
Schmoll, Friedrich
SpringerLink (Online service)

Other Objects (12)

Ability of ELISAs to detect antibodies against porcine respiratory and reproductive syndrome virus in serum of pigs after inactivated vaccination and subsequent challenge : Ability of ELISAs to detect antibodies against porcine respiratory andreproductive syndrome virus in serum of pigs after inactivated vaccination and subsequent challenge

Oral administration of inactivated porcine epidemic diarrhea virus activate DCs in porcine Peyer’s patches

Correction to: Oral administration of inactivated porcine epidemic diarrhea virus activate DCs in porcine Peyer’s patches

An inactivated vaccine made from a U.S. field isolate of porcine epidemic disease virus is immunogenic in pigs as demonstrated by a dose-titration

Nonspecific protection of heat-inactivated Mycobacterium bovis against Salmonella Choleraesuis infection in pigs

Characterizing the detection of inactivated Mycoplasma hyopneumoniae DNA in the respiratory tract of pigs

Immunogenicity evaluation of inactivated virus and purified proteins of porcine circovirus type 2 in mice

Safety and long-lasting immunity of the combined administration of a modified-live virus vaccine against porcine reproductive and respiratory syndrome virus 1 and an inactivated vaccine against porcine parvovirus and Erysipelothrix rhusiopathiae in breeding pigs

Layered double hydroxide nanoparticles as an adjuvant for inactivated foot-and-mouth disease vaccine in pigs

Adjuvant screening of the Senecavirus A inactivated vaccine in mice and evaluation of its immunogenicity in pigs

Effect of challenge of pigs previously immunised with inactivated vaccines containing homologous and heterologous Mycoplasma hyopneumoniae strains

Prevalence of porcine enterovirus 9 in pigs in Middle and Eastern China

Ability of ELISAs to detect antibodies against porcine respiratory and reproductive syndrome virus in serum of pigs after inactivated vaccination and subsequent challenge : Ability of ELISAs to detect antibodies against porcine respiratory andreproductive syndrome virus in serum of pigs after inactivated vaccination and subsequent challenge

Oral administration of inactivated porcine epidemic diarrhea virus activate DCs in porcine Peyer’s patches

Correction to: Oral administration of inactivated porcine epidemic diarrhea virus activate DCs in porcine Peyer’s patches

An inactivated vaccine made from a U.S. field isolate of porcine epidemic disease virus is immunogenic in pigs as demonstrated by a dose-titration

Nonspecific protection of heat-inactivated Mycobacterium bovis against Salmonella Choleraesuis infection in pigs

Characterizing the detection of inactivated Mycoplasma hyopneumoniae DNA in the respiratory tract of pigs

Immunogenicity evaluation of inactivated virus and purified proteins of porcine circovirus type 2 in mice

Safety and long-lasting immunity of the combined administration of a modified-live virus vaccine against porcine reproductive and respiratory syndrome virus 1 and an inactivated vaccine against porcine parvovirus and Erysipelothrix rhusiopathiae in breeding pigs

Layered double hydroxide nanoparticles as an adjuvant for inactivated foot-and-mouth disease vaccine in pigs

Adjuvant screening of the Senecavirus A inactivated vaccine in mice and evaluation of its immunogenicity in pigs

Effect of challenge of pigs previously immunised with inactivated vaccines containing homologous and heterologous Mycoplasma hyopneumoniae strains

Prevalence of porcine enterovirus 9 in pigs in Middle and Eastern China

Ability of ELISAs to detect antibodies against porcine respiratory and reproductive syndrome virus in serum of pigs after inactivated vaccination and subsequent challenge : Ability of ELISAs to detect antibodies against porcine respiratory andreproductive syndrome virus in serum of pigs after inactivated vaccination and subsequent challenge

Oral administration of inactivated porcine epidemic diarrhea virus activate DCs in porcine Peyer’s patches

Correction to: Oral administration of inactivated porcine epidemic diarrhea virus activate DCs in porcine Peyer’s patches

An inactivated vaccine made from a U.S. field isolate of porcine epidemic disease virus is immunogenic in pigs as demonstrated by a dose-titration

Nonspecific protection of heat-inactivated Mycobacterium bovis against Salmonella Choleraesuis infection in pigs

Characterizing the detection of inactivated Mycoplasma hyopneumoniae DNA in the respiratory tract of pigs

Immunogenicity evaluation of inactivated virus and purified proteins of porcine circovirus type 2 in mice

Safety and long-lasting immunity of the combined administration of a modified-live virus vaccine against porcine reproductive and respiratory syndrome virus 1 and an inactivated vaccine against porcine parvovirus and Erysipelothrix rhusiopathiae in breeding pigs

Layered double hydroxide nanoparticles as an adjuvant for inactivated foot-and-mouth disease vaccine in pigs

Adjuvant screening of the Senecavirus A inactivated vaccine in mice and evaluation of its immunogenicity in pigs

Effect of challenge of pigs previously immunised with inactivated vaccines containing homologous and heterologous Mycoplasma hyopneumoniae strains

Prevalence of porcine enterovirus 9 in pigs in Middle and Eastern China

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Ability of ELISAs to detect antibodies against porcine respiratory and reproductive syndrome virus in serum of pigs after inactivated vaccination and subsequent challenge

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Oral administration of inactivated porcine epidemic diarrhea virus activate DCs in porcine Peyer’s patches

Correction to: Oral administration of inactivated porcine epidemic diarrhea virus activate DCs in porcine Peyer’s patches

An inactivated vaccine made from a U.S. field isolate of porcine epidemic disease virus is immunogenic in pigs as demonstrated by a dose-titration

Nonspecific protection of heat-inactivated Mycobacterium bovis against Salmonella Choleraesuis infection in pigs

Characterizing the detection of inactivated Mycoplasma hyopneumoniae DNA in the respiratory tract of pigs

Immunogenicity evaluation of inactivated virus and purified proteins of porcine circovirus type 2 in mice

Safety and long-lasting immunity of the combined administration of a modified-live virus vaccine against porcine reproductive and respiratory syndrome virus 1 and an inactivated vaccine against porcine parvovirus and Erysipelothrix rhusiopathiae in breeding pigs

Layered double hydroxide nanoparticles as an adjuvant for inactivated foot-and-mouth disease vaccine in pigs

Adjuvant screening of the Senecavirus A inactivated vaccine in mice and evaluation of its immunogenicity in pigs

Effect of challenge of pigs previously immunised with inactivated vaccines containing homologous and heterologous Mycoplasma hyopneumoniae strains

Prevalence of porcine enterovirus 9 in pigs in Middle and Eastern China

Oral administration of inactivated porcine epidemic diarrhea virus activate DCs in porcine Peyer’s patches

Correction to: Oral administration of inactivated porcine epidemic diarrhea virus activate DCs in porcine Peyer’s patches

An inactivated vaccine made from a U.S. field isolate of porcine epidemic disease virus is immunogenic in pigs as demonstrated by a dose-titration

Nonspecific protection of heat-inactivated Mycobacterium bovis against Salmonella Choleraesuis infection in pigs

Characterizing the detection of inactivated Mycoplasma hyopneumoniae DNA in the respiratory tract of pigs

Immunogenicity evaluation of inactivated virus and purified proteins of porcine circovirus type 2 in mice

Safety and long-lasting immunity of the combined administration of a modified-live virus vaccine against porcine reproductive and respiratory syndrome virus 1 and an inactivated vaccine against porcine parvovirus and Erysipelothrix rhusiopathiae in breeding pigs

Layered double hydroxide nanoparticles as an adjuvant for inactivated foot-and-mouth disease vaccine in pigs

Adjuvant screening of the Senecavirus A inactivated vaccine in mice and evaluation of its immunogenicity in pigs

Effect of challenge of pigs previously immunised with inactivated vaccines containing homologous and heterologous Mycoplasma hyopneumoniae strains

Prevalence of porcine enterovirus 9 in pigs in Middle and Eastern China

Oral administration of inactivated porcine epidemic diarrhea virus activate DCs in porcine Peyer’s patches

Correction to: Oral administration of inactivated porcine epidemic diarrhea virus activate DCs in porcine Peyer’s patches

An inactivated vaccine made from a U.S. field isolate of porcine epidemic disease virus is immunogenic in pigs as demonstrated by a dose-titration

Nonspecific protection of heat-inactivated Mycobacterium bovis against Salmonella Choleraesuis infection in pigs

Characterizing the detection of inactivated Mycoplasma hyopneumoniae DNA in the respiratory tract of pigs

Immunogenicity evaluation of inactivated virus and purified proteins of porcine circovirus type 2 in mice

Safety and long-lasting immunity of the combined administration of a modified-live virus vaccine against porcine reproductive and respiratory syndrome virus 1 and an inactivated vaccine against porcine parvovirus and Erysipelothrix rhusiopathiae in breeding pigs

Layered double hydroxide nanoparticles as an adjuvant for inactivated foot-and-mouth disease vaccine in pigs

Adjuvant screening of the Senecavirus A inactivated vaccine in mice and evaluation of its immunogenicity in pigs

Effect of challenge of pigs previously immunised with inactivated vaccines containing homologous and heterologous Mycoplasma hyopneumoniae strains

Prevalence of porcine enterovirus 9 in pigs in Middle and Eastern China

Related objects

Reset password